Clinical utility of diagnostic markers for malignant pleural mesothelioma
نویسندگان
چکیده
منابع مشابه
Clinical utility of diagnostic markers for malignant pleural mesothelioma.
Malignant mesothelioma has a very dismal prognosis with very few patients surviving one year after diagnosis. Early multimodal treatment, however, is expected to improve the outcome. Today, there is a strong need to have disease markers which could be used for screening, diagnosing, and/or monitoring tumour response to treatment. Old markers such as hyaluronic acid, various cytokeratin fragment...
متن کاملMalignant pleural mesothelioma: utility of 18 F-FDG PET.
Malignant Pleural Mesothelioma is a rare tumour that arise from the mesothelial cells of the pleura and in recent time the incidence of this disease is rising. Because of the implications for management and therapy, it is important to assess the accurate staging. 18F-fluorodeoxiglucose Positron Emission Tomography (18F-FDG PET) is become a useful tool in the diagnosis of many neoplasms, such as...
متن کاملRadiotherapy for malignant pleural mesothelioma.
BACKGROUND Malignant pleural mesothelioma is a relatively uncommon disease, but the incidence is increasing and is expected to peak in many developed countries in the next two decades. The management of patients with malignant mesothelioma is controversial. Very few patients are suitable for any potentially curative treatment and the effectiveness of radical therapy with surgery, radiotherapy a...
متن کاملDiagnostic Imaging and workup of Malignant Pleural Mesothelioma.
Malignant pleural mesothelioma is the most frequent primary neoplasm of the pleura and its incidence is still increasing.This tumor has a strong association with exposure to occupational or environmental asbestos, often after a long latent period of 30-40 years.Plain chest radiography (CXR) is usually the first-line radiologic examination, but the radiographic findings are nonspecific due to it...
متن کاملDiagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions
STUDY OBJECTIVE To evaluate the diagnostic value of four different tumor markers: cancer antigen 125 (CA-125), carcinoembryonic antigen (CEA), cytokeratin 19 fragment (CYFRA 21-1) and neuron specific enolase (NSE) in patients with malignant and non-malignant pleural effusion. MATERIAL AND METHODS One hundred and two patients with pleural effusion treated in the University Hospital in Warsaw b...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Monaldi Archives for Chest Disease
سال: 2016
ISSN: 2465-1028,1122-0643
DOI: 10.4081/monaldi.2009.374